Upcoming events

    • June 15, 2020
    • 12:30 PM - 5:00 PM (UTC-04:00)
    • Zoom Webinar

    Buprenorphine X-Waiver Training Webinar

    DATE: Monday,  June 15, 2020
    TIME: 12:30-5:00 p.m. CST
    LOCATION: Zoom Webinar (Link provided once registered)

    PRESENTER: Subhadeep Barman, MD, DFASAM

    After registering, you will receive a confirmation email containing information about joining the webinar. There is a limited number of spots available. 

    Register here!

    Training is provided complimentary to Wisconsin providers who are eligible to prescribe buprenorphine.  This session is presented as a live four-hour activity, which, when paired with ASAM's four-hour on-demand course, will provide necessary education for participates to apply for and obtain their  Buprenorphine Waver through the American Society of Addiction Medicine. 


    ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. This blended format combines 4 hours of self-paced online learning with 4 hours of live learning for a total of 8 hours.  The online portion is completed before the live portion and will introduce learners to treating opioid use disorder with medications. Prior to the live course, learners will be issued access to the online portion of the blended course through the ASAM e-Learning Center. The live portion of the course focuses on special populations and cases.

    ACCREDITATION: The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    DESIGNATION: The American Society of Addiction Medicine designates this live activity for a maximum of AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The American Society of Addiction Medicine designates this enduring material for a maximum of AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ASAM does not award partial credit for this 8-hour course. All 8 hours must be completed to receive CME credit.

    • July 16, 2020
    • (UTC-04:00)
    • July 17, 2020
    • (UTC-04:00)

    The Essential Primer in Addiction Medicine…

    The Board Exam Study Course (BESC) is the essential primer for physicians and other healthcare professionals who are preparing for a career in addiction medicine, and for primary care providers who wish to increase their skills in identifying and managing patients whose medical problems are caused or exacerbated by substance use disorders.

    The course offers two days of live-stream sessions on Thursday, July 16 and Friday, July 17, as well as additional on-demand sessions which are mapped to the addiction medicine exam blueprint of topics and feature an outstanding lineup of faculty. Following the live virtual event, all sessions will be available on-demand for the next three years in ASAM’s e-Learning Center.

    Click here for more information and to register online.

    Learning Objectives

    Upon completion, participants should be able to:
    1. Demonstrate practical knowledge on the neurobiology of addiction and articulate its activity in terms useful in a clinical setting
    2. Describe the effects of alcohol, tobacco and other drugs in both tolerant and non-tolerant individuals
    3. Describe the process for diagnosing addiction and differentiating the symptoms of addiction from those of other medical or psychiatric disorders
    4. Explain the various pharmacologic and psychosocial treatments for addictive disorders and describe the factors that should be considered in selecting a treatment modality to match the needs of a specific patient
    5. Describe the precipitants of relapse and current evidence-based practices to prevent and manage relapse

    Who Should Participate

    The BESC provides an up-to-date review of the core content of addiction medicine for:

    • Physicians preparing for the ABPM Board Certification Examination in addiction medicine
    • Addiction specialists seeking a "refresher" course that incorporates recent developments in addiction science and practice
    • Non-specialist physicians and other healthcare professionals seeking the knowledge to identify and manage problems related to substance use disorders for their patients  
    • July 21, 2020
    • 12:30 PM - 5:00 PM (UTC-04:00)
    • Zoom Webinar

    Buprenorphine X-Waiver Training Webinar

    DATE: Tuesday, July 21, 2020
    TIME: 12:30-5:00 p.m. CST
    LOCATION: Zoom Webinar (Link provided once registered)

    PRESENTER: Mark Lim, MD

    After registering, you will receive a confirmation email containing information about joining the webinar. There is a limited number of spots available. 

    Register here!

    Training is provided complimentary to Wisconsin providers who are eligible to prescribe buprenorphine.  This session is presented as a live four-hour activity, which, when paired with ASAM's four-hour on-demand course, will provide necessary education for participates to apply for and obtain their  Buprenorphine Waver through the American Society of Addiction Medicine. 


    ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. This blended format combines 4 hours of self-paced online learning with 4 hours of live learning for a total of 8 hours.  The online portion is completed before the live portion and will introduce learners to treating opioid use disorder with medications. Prior to the live course, learners will be issued access to the online portion of the blended course through the ASAM e-Learning Center. The live portion of the course focuses on special populations and cases.

    ACCREDITATION: The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    DESIGNATION: The American Society of Addiction Medicine designates this live activity for a maximum of AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The American Society of Addiction Medicine designates this enduring material for a maximum of AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ASAM does not award partial credit for this 8-hour course. All 8 hours must be completed to receive CME credit.

    • August 18, 2020
    • 12:30 PM - 5:00 PM (UTC-04:00)
    • Zoom Webinar

    Buprenorphine X-Waiver Training Webinar

    DATE: Monday, September 14, 2020
    TIME: 12:30-5:00 p.m. CST
    LOCATION: Zoom Webinar (Link provided once registered)

    PRESENTER: David Galbis-Reig, MD, DFASAM

    After registering, you will receive a confirmation email containing information about joining the webinar. There is a limited number of spots available. 

    Register here!

    Training is provided complimentary to Wisconsin providers who are eligible to prescribe buprenorphine.  This session is presented as a live four-hour activity, which, when paired with ASAM's four-hour on-demand course, will provide necessary education for participates to apply for and obtain their  Buprenorphine Waver through the American Society of Addiction Medicine. 


    ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. This blended format combines 4 hours of self-paced online learning with 4 hours of live learning for a total of 8 hours.  The online portion is completed before the live portion and will introduce learners to treating opioid use disorder with medications. Prior to the live course, learners will be issued access to the online portion of the blended course through the ASAM e-Learning Center. The live portion of the course focuses on special populations and cases.

    ACCREDITATION: The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    DESIGNATION: The American Society of Addiction Medicine designates this live activity for a maximum of AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The American Society of Addiction Medicine designates this enduring material for a maximum of AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ASAM does not award partial credit for this 8-hour course. All 8 hours must be completed to receive CME credit.

    • August 26, 2020
    • (UTC-04:00)
    • August 28, 2020
    • (UTC-04:00)
    • Minneapolis, MN


    Join the American College of Medical Toxicology (ACMT) for the 2020 Total Tox Course! Lead by numerous nationally and internationally recognized experts in medical toxicology and emergency medicine, this course will be offered August 26-28, 2020 at the Hyatt Regency in Minneapolis, MN.

    The 3-day course will focus on medical toxicology topics of interest to acute care providers, including toxicological issues of current clinical and public health importance. Attendees will be presented with state-of-the-art updates on the evaluation and initial management of poisoning and exposure to medications, drugs of abuse, chemical terrorism, and environmental toxins. The course will be an in-depth review of the scope of acute care toxicology and include cutting-edge interventions and management options for poisoned patients.

    This course is recommended by:

    American Academy of Emergency Medicine (AAEM)
    Illinois College of Emergency Physicians (ICEP)
    Wisconsin Society of Addiction Medicine (WISAM)

    Target Audience: Pharmacists, Physicians, Mid-Level Providers, Nurses, Medics, EMTs, SPIs, Poison Center Educators, First Responders, Operational or Tactical Specialists

     Topics include:

    • Over-the-Counter Poisons
    • Drugs of Abuse
    • Ethanol and Other Toxic Alcohols
    • Heavy Metals
    • Chemical Suicide
    • Disaster Preparedness: Radiation Events, Nerve Agents, and Chemical Terrorism
    • Beta Blockers and Calcium Channel Blockers
    • Endocrine Agents
    • Envenomations
    • The Toxic House: Dangers in Your Garage & Cabinets

    And Much, Much More!

     Continuing Medical Education (CME) and Continuing Pharmacy Education (CPE) credits available. Early-Bird registration discount ends July 15, 2020.

     Find Out More: www.acmt.net/TotalTox_Overview

    • September 14, 2020
    • 12:30 PM - 5:00 PM (UTC-04:00)
    • Zoom Webinar

    Buprenorphine X-Waiver Training Webinar

    DATE: Monday, September 14, 2020
    TIME: 12:30-5:00 p.m. CST
    LOCATION: Zoom Webinar (Link provided once registered)

    PRESENTER: Alison Miller, MD

    After registering, you will receive a confirmation email containing information about joining the webinar. There is a limited number of spots available. 

    Register here!

    Training is provided complimentary to Wisconsin providers who are eligible to prescribe buprenorphine.  This session is presented as a live four-hour activity, which, when paired with ASAM's four-hour on-demand course, will provide necessary education for participates to apply for and obtain their  Buprenorphine Waver through the American Society of Addiction Medicine. 


    ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. This blended format combines 4 hours of self-paced online learning with 4 hours of live learning for a total of 8 hours.  The online portion is completed before the live portion and will introduce learners to treating opioid use disorder with medications. Prior to the live course, learners will be issued access to the online portion of the blended course through the ASAM e-Learning Center. The live portion of the course focuses on special populations and cases.

    ACCREDITATION: The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    DESIGNATION: The American Society of Addiction Medicine designates this live activity for a maximum of AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The American Society of Addiction Medicine designates this enduring material for a maximum of AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ASAM does not award partial credit for this 8-hour course. All 8 hours must be completed to receive CME credit.

    • October 01, 2020
    • (UTC-04:00)
    • October 02, 2020
    • (UTC-04:00)
    • The Pyle Center

    SAVE | THE | DATE

    Thursday, October 1 and Friday, October 2, 2020

    More Details Soon!

    • October 23, 2020
    • 12:30 PM - 5:00 PM (UTC-03:00)
    • Zoom Webinar

    Buprenorphine X-Waiver Training Webinar

    DATE: Friday,  October 23, 2020
    TIME: 12:30-5:00 p.m. CST
    LOCATION: Zoom Webinar (Link provided once registered)

    PRESENTER: Alison Miller, MD

    After registering, you will receive a confirmation email containing information about joining the webinar. There is a limited number of spots available. 

    Register here!

    Training is provided complimentary to Wisconsin providers who are eligible to prescribe buprenorphine.  This session is presented as a live four-hour activity, which, when paired with ASAM's four-hour on-demand course, will provide necessary education for participates to apply for and obtain their  Buprenorphine Waver through the American Society of Addiction Medicine. 


    ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. This blended format combines 4 hours of self-paced online learning with 4 hours of live learning for a total of 8 hours.  The online portion is completed before the live portion and will introduce learners to treating opioid use disorder with medications. Prior to the live course, learners will be issued access to the online portion of the blended course through the ASAM e-Learning Center. The live portion of the course focuses on special populations and cases.

    ACCREDITATION: The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    DESIGNATION: The American Society of Addiction Medicine designates this live activity for a maximum of AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The American Society of Addiction Medicine designates this enduring material for a maximum of AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ASAM does not award partial credit for this 8-hour course. All 8 hours must be completed to receive CME credit.

    • November 17, 2020
    • 12:30 PM - 5:00 PM (UTC-03:00)
    • Zoom Webinar

    Buprenorphine X-Waiver Training Webinar

    DATE: Tuesday, November 17, 2020
    TIME: 12:30-5:00 p.m. CST
    LOCATION: Zoom Webinar (Link provided once registered)

    PRESENTER: David Galbis-Reig, MD, DFASAM

    After registering, you will receive a confirmation email containing information about joining the webinar. There is a limited number of spots available. 

    Register here!

    Training is provided complimentary to Wisconsin providers who are eligible to prescribe buprenorphine.  This session is presented as a live four-hour activity, which, when paired with ASAM's four-hour on-demand course, will provide necessary education for participates to apply for and obtain their  Buprenorphine Waver through the American Society of Addiction Medicine. 


    ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. This blended format combines 4 hours of self-paced online learning with 4 hours of live learning for a total of 8 hours.  The online portion is completed before the live portion and will introduce learners to treating opioid use disorder with medications. Prior to the live course, learners will be issued access to the online portion of the blended course through the ASAM e-Learning Center. The live portion of the course focuses on special populations and cases.

    ACCREDITATION: The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    DESIGNATION: The American Society of Addiction Medicine designates this live activity for a maximum of AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The American Society of Addiction Medicine designates this enduring material for a maximum of AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ASAM does not award partial credit for this 8-hour course. All 8 hours must be completed to receive CME credit.

    • May 05, 2021
    • (UTC-04:00)
    • Madison, WI

    The multi-specialty nature of Doctor Day makes Wisconsin's annual physicians' advocacy event unique compared to similar events across the country.  Physicians and medical students from nearly 20 different physician organizations participate in Doctor Day.

    Learn first-hand how you can make a difference in the legislative process!  Make your voice heard at Doctor Day.

    Website: https://www.widoctorday.org/

Past events

May 29, 2020 Buprenorphine X-Waiver Training Webinar
May 22, 2020 Buprenorphine X-Waiver Training Webinar
May 15, 2020 Buprenorphine X-Waiver Training Webinar
May 05, 2020 DHS 2020 Opioid Forum (Postponed)
April 30, 2020 OUD & the Emergency Department Experience During the COVID-19 Pandemic
April 24, 2020 Buprenorphine X-Waiver Course (Cancelled)
April 24, 2020 Buprenorphine X-Waiver Course (Cancelled)
April 17, 2020 WMS Annual Fundraising Silent Auction: ONLINE!
April 15, 2020 Newsmaker webinar with Froedtert Health CEO Cathy Jacobson
April 14, 2020 WI DHS COVID-19 Videoconference for Behavioral Health Providers
April 09, 2020 WI DHS COVID-19 Videoconference for Behavioral Health Providers
April 07, 2020 COVID-19 update with Marshfield Clinic Health System CEO Dr. Sue Turney
April 07, 2020 Webinar - How the Stimulus Can Help You
April 02, 2020 ASAM 2020 Annual Conference (ONLINE)
March 26, 2020 Town Hall Teleconference Call
March 17, 2020 Buprenorphine X-Waiver Course (Cancelled)
February 27, 2020 Town Hall Teleconference Call
February 18, 2020 Buprenorphine X-Waiver Course
February 10, 2020 Newsmaker Event - Deputy Insurance Commissioner Nathan Houdek
January 29, 2020 Doctor Day 2020
January 23, 2020 Town Hall Teleconference Call
November 06, 2019 Buprenorphine X-Waiver Course
October 28, 2019 Buprenorphine X-Waiver Course
October 21, 2019 National Addiction Treatment Week
October 15, 2019 2nd Annual WI Opioid & Meth Summit
September 26, 2019 WISAM 2019 Annual Conference
September 26, 2019 WISAM 2019 Annual Conference Vendors
August 27, 2019 Buprenorphine X-Waiver Course
August 16, 2019 Buprenorphine X-Waiver Course
July 29, 2019 Buprenorphine X-Waiver Course
July 25, 2019 ASAM Review Course in Addiction Medicine
July 16, 2019 Buprenorphine X-Waiver Course
June 28, 2019 Buprenorphine X-Waiver Course
June 04, 2019 Buprenorphine X-Waiver Course
May 23, 2019 WISAM Telephone Town Hall
May 22, 2019 Complex Pain Case Conference
May 17, 2019 Buprenorphine X-Waiver Course
May 16, 2019 Overcoming Addiction Together
April 16, 2019 Buprenorphine X-Waiver Course
April 06, 2019 WISAM Meeting at ASAM 50th Annual Conference
April 05, 2019 From Asthma to Zika: A Physician's Guide to Summer
March 28, 2019 WISAM Telephone Town Hall
March 18, 2019 Buprenorphine X-Waiver Course
February 28, 2019 WISAM Telephone Town Hall
February 20, 2019 Buprenorphine X-Waiver Course
January 24, 2019 WISAM Telephone Town Hall
September 29, 2018 WISAM 2018 CLINICAL WORKSHOPS
September 27, 2018 WISAM 2018 Annual Conference
September 27, 2018 WISAM 2018 Annual Conference Vendors
July 10, 2018 WHN Panel Series Event
June 20, 2018 WISAM 2018 Webinar Series
May 08, 2018 Treating an Epidemic: Solutions and Challenges in Overcoming the Opioid Crisis
April 13, 2018 Wisconsin Medical Society Foundation: Annual Fundraising Dinner and Silent Auction
April 12, 2018 ASAM 49th Annual Conference
January 30, 2018 2018 Doctor Day
September 14, 2017 2017 Wisconsin Society of Addiction Medicine Annual Conference
September 14, 2017 WISAM 2017 Annual Conference Vendor
August 30, 2017 The Opioid Crisis: Innovative Health Communication Strategies
July 19, 2017 WI Health News Conference: Health Reform: What does it mean for Wisconsin?
June 05, 2017 WI Health News: JFC Co-Chair Nygren to headline June 5 Newsmaker Event
April 24, 2017 Addiction Treatment Gap Awareness

Contact WISAM

563 Carter Court, Suite B
Kimberly, WI 54136
920-750-7727
WISAM@badgerbay.co


Social Media Center

Donate Today!

Help fund WISAM
WISAM is funded in part by generous donations from patrons such as yourself.  Click here to make your donation today.  Your donation is tax deductible.

Copyright © 2018 WISAM All rights reserved.  | Terms of Use | Privacy Policy

The Wisconsin Society of Addiction Medicine (WISAM) is headquartered in Kimberly, WI.
Contact us today for more information about our organization!

Powered by Wild Apricot Membership Software